Shopping Cart 0
Cart Subtotal
AED 0

Tillotts Pharma AG - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: No
Copy Option: No
Download Option: No
Deliverable Format : PDF viewable on the website via username

Single User License
AED 918

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: No
Copy Option: No
Download Option: No
Deliverable Format : PDF viewable on the website via username

Site License
AED 1835

Multiple Users within the Company/ Enterprise
Print Option: Yes
Copy Option: Yes
Download Option: Yes
Deliverable Format : Excel, PDF viewable on the website via username

Corporate User License
AED 2753

Details

Summary

Tillotts Pharma AG (Tillotts) a subsidiary of Zeria Pharmaceutical Co Ltd is a healthcare solution provider that develops, licenses and markets pharmaceutical products, medical devices and diagnostics in the field of gastroenterology. The company's products are used for the treatment of various diseases including ulcerative colitis, digestive systems and crohn's disease, bowel spasms and others. Tillotts offers contract manufacturing services. It distributes its products through its affiliates and also through a network of distributors and licensees across Europe and the Middle East. The company has a presence in Czech Republic, Ireland, Sweden, Spain, Germany and the UK. Tillotts is headquartered in Rheinfelden, Switzerland.

Tillotts Pharma AG-Pharmaceuticals & Healthcare-Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals-Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.

- Deals by Year-Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.

- Deals by Type-Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.

- Deals by Region-Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.

- Deals by Sub-sector-Chart and table showing information on the number of deals and value reported by the company, by sub-sector.

- Major Deals-Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company's (major public companies) key financial metrics and ratios.

- Business Description-A brief description of the company's operations.

- Key Employees-A list of the key executives of the company.

- Important Locations and Subsidiaries-A list and contact details of key centers of operation and subsidiaries of the company.

- Key Competitors-A list of the key competitors of the company.

- Key Recent Developments-A brief on recent news about the company.

Reasons to buy

Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements

- The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company's business segments' expansion / divestiture strategy

- The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.

Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company

- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios.

Equip yourself with detailed information about the company's operations to identify potential customers and suppliers.

- The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company

- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research

- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

READ MORE

Table Of Content

Scope

Table of Contents

Table of Contents 3

List of Tables 4

List of Figures 4

Tillotts Pharma AG, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5

Tillotts Pharma AG, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6

Tillotts Pharma AG, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7

Tillotts Pharma AG, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8

Tillotts Pharma AG, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9

Tillotts Pharma AG, Pharmaceuticals & Healthcare, Deal Details 10

Asset Purchase 10

Tillotts Pharma Acquires Entocort from AstraZeneca 10

Partnerships 11

PendoPharm Enters into Distribution Agreement with Tillotts Pharma 11

Solid Form Solutions Enters Into Co-Promotion Agreement With Tillotts Pharma 12

Licensing Agreements 13

Tillotts Pharma Enters into Licensing Agreement with BioWa and Lonza 13

Tillotts Pharma Enters into Licensing Agreement with Inven2 14

Tillotts Pharma Enters into Licensing Agreement with Numab 15

Tillotts Pharma Amends Licensing Agreement with Cancer Prevention Pharma 16

Tillotts Pharma AG-Key Competitors 18

Tillotts Pharma AG-Key Employees 19

Tillotts Pharma AG-Locations And Subsidiaries 20

Head Office 20

Other Locations & Subsidiaries 20

Recent Developments 21

Strategy And Business Planning 21

Mar 05, 2018: Tillotts Pharma opens new, state-of-the-art office in Rheinfelden, Switzerland 21

Feb 23, 2017: Tillotts Pharma in Germany Dedicated to Gastrointestinal Health 22

Corporate Communications 23

May 04, 2018: Tillotts Pharma Announces Resignation Of Prof. Dr. Ulrich Mittmann And Dr. Roberto Gradnik Step Down From Board 23

Appendix 24

Methodology 24

About GlobalData 24

Contact Us 24

Disclaimer 24


List Of Figure

List of Figures

Tillotts Pharma AG, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2

Tillotts Pharma AG, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2

Tillotts Pharma AG, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2

Tillotts Pharma AG, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2

Tillotts Pharma AG, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5

Tillotts Pharma AG, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6

Tillotts Pharma AG, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7

Tillotts Pharma AG, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8


List Of Table

List of Tables

Tillotts Pharma AG, Pharmaceuticals & Healthcare, Key Facts 2

Tillotts Pharma AG, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5

Tillotts Pharma AG, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6

Tillotts Pharma AG, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7

Tillotts Pharma AG, Deals By Therapy Area, 2012 to YTD 2018 8

Tillotts Pharma AG, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9

Tillotts Pharma Acquires Entocort from AstraZeneca 10

PendoPharm Enters into Distribution Agreement with Tillotts Pharma 11

Solid Form Solutions Enters Into Co-Promotion Agreement With Tillotts Pharma 12

Tillotts Pharma Enters into Licensing Agreement with BioWa and Lonza 13

Tillotts Pharma Enters into Licensing Agreement with Inven2 14

Tillotts Pharma Enters into Licensing Agreement with Numab 15

Tillotts Pharma Amends Licensing Agreement with Cancer Prevention Pharma 16

Tillotts Pharma AG, Key Competitors 18

Tillotts Pharma AG, Key Employees 19

Tillotts Pharma AG, Subsidiaries 20

Licence Rights

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License: 
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

Section Purchase

To know more information on Purchase by Section, please send a mail to support@kenresearch.com

INQUIRE FOR COVID-19 IMPACT ANALYSIS

Products and Companies

Products

Tillotts Pharma AG, Deal Analysis, Mergers, Acquisitions, Asset Purchases, Asset Divestitures, Company Divestitures, Equity Offerings, Capital Raising, Debt Offerings, IPOs, Initial Public Offering, Private Placement, Private Investment In Public Equities, Secondary Offerings, Follow-On Offerings, Debt Private Placement, Public Debt Placement, Partnerships, Joint Venture, Licensing Agreements, Co-Marketing Agreements, Upfront Payment, Milestone Payment, Phases, Clinical Trials, Private Equity, Venture Capital, PE,VC, Asset Finance, Project Finance, Tax Equity Financing, Bond Financing, Lease Financing, New Build Financing, Deal Analysis By Market/sector, Deal Analysis By Geography, Deal Analysis By Deal Types, Key Employees, Locations And Subsidiaries, Competitors, Recent News, Company Overview, Key Facts, Deals By Year, Deal Details, Recent Developments, Significant Developments.

Company Profile

Company Profile Title

Summary

Tillotts Pharma AG (Tillotts) a subsidiary of Zeria Pharmaceutical Co Ltd is a healthcare solution provider that develops, licenses and markets pharmaceutical products, medical devices and diagnostics in the field of gastroenterology. The company's products are used for the treatment of various diseases including ulcerative colitis, digestive systems and crohn's disease, bowel spasms and others. Tillotts offers contract manufacturing services. It distributes its products through its affiliates and also through a network of distributors and licensees across Europe and the Middle East. The company has a presence in Czech Republic, Ireland, Sweden, Spain, Germany and the UK. Tillotts is headquartered in Rheinfelden, Switzerland.

Tillotts Pharma AG-Pharmaceuticals & Healthcare-Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals-Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.

- Deals by Year-Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.

- Deals by Type-Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.

- Deals by Region-Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.

- Deals by Sub-sector-Chart and table showing information on the number of deals and value reported by the company, by sub-sector.

- Major Deals-Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company's (major public companies) key financial metrics and ratios.

- Business Description-A brief description of the company's operations.

- Key Employees-A list of the key executives of the company.

- Important Locations and Subsidiaries-A list and contact details of key centers of operation and subsidiaries of the company.

- Key Competitors-A list of the key competitors of the company.

- Key Recent Developments-A brief on recent news about the company.

Reasons to buy

Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements

- The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company's business segments' expansion / divestiture strategy

- The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.

Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company

- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios.

Equip yourself with detailed information about the company's operations to identify potential customers and suppliers.

- The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company

- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research

- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

READ MORE

Scope

Table of Contents

Table of Contents 3

List of Tables 4

List of Figures 4

Tillotts Pharma AG, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5

Tillotts Pharma AG, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6

Tillotts Pharma AG, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7

Tillotts Pharma AG, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8

Tillotts Pharma AG, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9

Tillotts Pharma AG, Pharmaceuticals & Healthcare, Deal Details 10

Asset Purchase 10

Tillotts Pharma Acquires Entocort from AstraZeneca 10

Partnerships 11

PendoPharm Enters into Distribution Agreement with Tillotts Pharma 11

Solid Form Solutions Enters Into Co-Promotion Agreement With Tillotts Pharma 12

Licensing Agreements 13

Tillotts Pharma Enters into Licensing Agreement with BioWa and Lonza 13

Tillotts Pharma Enters into Licensing Agreement with Inven2 14

Tillotts Pharma Enters into Licensing Agreement with Numab 15

Tillotts Pharma Amends Licensing Agreement with Cancer Prevention Pharma 16

Tillotts Pharma AG-Key Competitors 18

Tillotts Pharma AG-Key Employees 19

Tillotts Pharma AG-Locations And Subsidiaries 20

Head Office 20

Other Locations & Subsidiaries 20

Recent Developments 21

Strategy And Business Planning 21

Mar 05, 2018: Tillotts Pharma opens new, state-of-the-art office in Rheinfelden, Switzerland 21

Feb 23, 2017: Tillotts Pharma in Germany Dedicated to Gastrointestinal Health 22

Corporate Communications 23

May 04, 2018: Tillotts Pharma Announces Resignation Of Prof. Dr. Ulrich Mittmann And Dr. Roberto Gradnik Step Down From Board 23

Appendix 24

Methodology 24

About GlobalData 24

Contact Us 24

Disclaimer 24


List Of Figure

List of Figures

Tillotts Pharma AG, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2

Tillotts Pharma AG, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2

Tillotts Pharma AG, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2

Tillotts Pharma AG, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2

Tillotts Pharma AG, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5

Tillotts Pharma AG, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6

Tillotts Pharma AG, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7

Tillotts Pharma AG, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8


List Of Table

List of Tables

Tillotts Pharma AG, Pharmaceuticals & Healthcare, Key Facts 2

Tillotts Pharma AG, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5

Tillotts Pharma AG, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6

Tillotts Pharma AG, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7

Tillotts Pharma AG, Deals By Therapy Area, 2012 to YTD 2018 8

Tillotts Pharma AG, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9

Tillotts Pharma Acquires Entocort from AstraZeneca 10

PendoPharm Enters into Distribution Agreement with Tillotts Pharma 11

Solid Form Solutions Enters Into Co-Promotion Agreement With Tillotts Pharma 12

Tillotts Pharma Enters into Licensing Agreement with BioWa and Lonza 13

Tillotts Pharma Enters into Licensing Agreement with Inven2 14

Tillotts Pharma Enters into Licensing Agreement with Numab 15

Tillotts Pharma Amends Licensing Agreement with Cancer Prevention Pharma 16

Tillotts Pharma AG, Key Competitors 18

Tillotts Pharma AG, Key Employees 19

Tillotts Pharma AG, Subsidiaries 20

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License: 
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

To know more information on Purchase by Section, please send a mail to support@kenresearch.com

INQUIRE FOR COVID-19 IMPACT ANALYSIS

Products

Tillotts Pharma AG, Deal Analysis, Mergers, Acquisitions, Asset Purchases, Asset Divestitures, Company Divestitures, Equity Offerings, Capital Raising, Debt Offerings, IPOs, Initial Public Offering, Private Placement, Private Investment In Public Equities, Secondary Offerings, Follow-On Offerings, Debt Private Placement, Public Debt Placement, Partnerships, Joint Venture, Licensing Agreements, Co-Marketing Agreements, Upfront Payment, Milestone Payment, Phases, Clinical Trials, Private Equity, Venture Capital, PE,VC, Asset Finance, Project Finance, Tax Equity Financing, Bond Financing, Lease Financing, New Build Financing, Deal Analysis By Market/sector, Deal Analysis By Geography, Deal Analysis By Deal Types, Key Employees, Locations And Subsidiaries, Competitors, Recent News, Company Overview, Key Facts, Deals By Year, Deal Details, Recent Developments, Significant Developments.